Skip to main content
. 2023 Feb 9;66(4):2663–2680. doi: 10.1021/acs.jmedchem.2c01627

Figure 3.

Figure 3

Dose–responses observed for nitrile- or alkyne-bearing SARS-CoV-2 Mpro inhibitors. Representative dose–response curves of Mpro inhibitors shown in (a) Table 1, (b) Table 2, and (c) Table 3. High Z′-factors66 (>0.5 for each inhibition plate) indicate excellent solid-phase extraction coupled to mass spectrometry (SPE-MS) assay quality (Supporting Figure S5).